The case in front of me: HJ · liraglutide.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What can I legitimately conclude from this figure?
The case in front of me: HJ · liraglutide.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What can I legitimately conclude from this figure?
The relevant detail is that ask whether the certificate answers the question you are actually asking, because the answer is often no.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 7 Nov 2024 by lyoph_cake — added the placebo-arm figures
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsReading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
Concretely, a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
If the certificate does not trace to your vial, it is not evidence about your vial.
Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
My working rule is that a document without a lot number, a method section and a test date is marketing.
The certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 6 Dec 2024 by hana_petrikova — added the method parameters
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.